<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>32</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">David Triest</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Fusarium, clinical relevance and mass spectrometry methods for identification, using strains of the Belgian fungal culture collection BCCM/IHEM</style></title></titles><keywords><keyword><style  face="normal" font="default" size="100%">BCCM/IHEM</style></keyword><keyword><style  face="normal" font="default" size="100%">Belgian fungal culture collection</style></keyword><keyword><style  face="normal" font="default" size="100%">Fusarium</style></keyword><keyword><style  face="normal" font="default" size="100%">identification</style></keyword><keyword><style  face="normal" font="default" size="100%">Mass Spectrometry</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2017</style></date></pub-dates></dates><publisher><style face="normal" font="default" size="100%">VUB</style></publisher><pub-location><style face="normal" font="default" size="100%">Brussels, Belgium</style></pub-location><pages><style face="normal" font="default" size="100%">180</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;A correct identification of mold species causing human infections is of the utmost importance since treatment may differ depending on the infecting species. However, this is still a challenge in the current clinical practice, relying upon a morphological examination of a cultured isolate. In the first part of this PhD the focus was on Fusarium, a mold genus causing a wide variety of opportunistic human infections. In order to study the clinically relevant species diversity, the more than 300 Fusarium strains in the Belgian fungal culture collection BCCM/IHEM, mostly isolated from patients, were re-identified by multilocus DNA marker sequencing and phylogeny. The remaining 289 validated strains, comprising 40 different species, were of great value: (i) Analysis of the strain information revealed a species, i.e. Fusarium musae, of which it was not yet known that it caused human infections. (ii) A new species, closely related to Fusarium, was described, i.e. Pseudofusicolla biseptata. (iii) In vitro antifungal susceptibility testing was performed on the Fusarium dataset showing the importance of a correct species (complex) identification. (iv) The Fusarium dataset was used to prove the feasibility of the MALDI-TOF mass spectrometry identification as opposed to the, often difficult, morphological identification. In the second part of this PhD the focus was on the development of a new identification method for mold infections which is directly applicable on clinical samples and relies upon the detection of species- and genus-specific peptides using tandem mass spectrometry. Candidate peptides were selected according to a mass spectrometry based proteomics study. Accurate genus identification of Fusarium and species identification of Aspergillus BCCM/IHEM collection material was possible and the new method was optimized for the analysis of clinical samples.&lt;/p&gt;
</style></abstract><accession-num><style face="normal" font="default" size="100%">NA</style></accession-num></record></records></xml>